70 results on '"Schmieder R"'
Search Results
2. AORTIC STIFFNESS IS NOT ONLY ASSOCIATED WITH STRUCTURAL BUT ALSO WITH FUNCTIONAL PARAMETERS OF MICROCIRCULATION
3. SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY
4. CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY
5. EARLY VASCULAR PARAMETERS IN THE MICRO- AND MACROCIRCULATION IN TYPE 2 DIABETES
6. [OP.7A.01] THE GLOBAL SYMPLICITY REGISTRY
7. [LB.03.06] ATTENUATION OF SPLANCHNIC AUTOTRANSFUSION FOLLOWING NON-INVASIVE ULTRASOUND RENAL DENERVATION
8. 8B.04
9. IMPACT OF RENAL NERVE ABLATION ON RENAL PERFUSION AND COMPONENTS OF THE RAAS IN TREATMENT RESISTANT HYPERTENSION
10. BLOOD PRESSURE REDUCTION IN 7000 ELDERLY HYPERTENSIVE PATIENTS: RESULTS FROM THE 3A REGISTRY
11. WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES IS RELATED TO ALTERATIONS OF AORTIC PULSE WAVE IN PATIENTS WITH A HISTORY OF A CEREBROVASCULAR EVENT
12. REAL LIFE ANALYSIS AND BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS CLASSIFIED BY THE SEVERITY OF BLOOD PRESSURE - RESULTS FROM THE 3A REGISTRY
13. PHYSICIAN INERTIA IN RELATION TO ACHIEVEMENT OF BP GOALS IN HYPERTENSIVE PATIENTS WITH COMORBIDITIES IN THE SHARE SURVEY
14. BLOOD PRESSURE REDUCTION IN CARDIO-RENAL HYPERTENSIVE PATIENTS: RESULTS FROM THE 3A REGISTRY
15. SUPERIOR BLOOD PRESSURE REDUCTION WITH ALISKIREN IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS IN REAL LIFE. RESULTS OF THE 3A REGISTRY
16. REAL LIFE ANALYSIS OF BLOOD PRESSURE REDUCTION IN OVER 5000 RESISTANT HYPERTENSIVE PATIENTS:RESULTS FROM THE 3A REGISTRY
17. BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIAL
18. HEMODYNAMIC EFFECTS OF ALISKIREN ARE SUSTAINED IN THE SYSTEMIC, BUT NOT THE RENAL CIRCULATION
19. FCG RECEPTOR IIA GENOTYPE, AFFECTING BINDING OF C-REACTIVE PROTEIN TO PHAGOZYTES IN VITRO, IS ASSOCIATED WITH ENDOTHELIAL FUNCTION IN VIVO: 1D.05
20. INVESTIGATING THE CRITICAL SITUATION IN HYPERTENSION MANAGEMENT: DISPARITIES BETWEEN THE PERCEPTION AND REALITY OF THE BURDEN OF ‘CHALLENGING PATIENTS’ (SHARE SURVEY): PP.26.55
21. STATIN TREATMENT AND ENDOTHELIAL FUNCTION IN HYPERTENSIVE SUBJECTS WITH NORMAL LDL-CHOLESTEROL LEVELS: PP.6.240
22. INVESTIGATING THE CRITICAL SITUATION IN HYPERTENSION MANAGEMENT: IS PHYSICIAN INERTIA PUTTING PATIENTS AT INCREASED CARDIOVASCULAR RISK? (SHARE SURVEY): 4B.06
23. RISK FACTOR ANALYSIS OF CARDIOVASCULAR EVENTS IN PATIENTS ON HAEMODIALYSIS (THE AURORA STUDY): PP.9.347
24. COMPARISON OF TWO NON-INVASIVE DEVICES (SPHYGMOCOR® VS. A-PULSE®) FOR MEASUREMENT OF CENTRAL HAEMODYNAMICS WITH INVASIVE MEASUREMENT DURING CARDIAC CATHETERIZATION: PP.3.97
25. ASSOCIATION OF (PRO)RENIN RECEPTOR GENE POLYMORPHISM WITH BLOOD PRESSURE IN MEN: PP.21.331
26. CHANGES IN ALBUMINURIA PREDICT MORTALITY AND MORBIDITY IN PATIENTS WITH VASCULAR DISEASE: PS.3.04
27. EFFECTS OF MANIDIPINE VERSUS AMLODIPINE ON INTRAGLOMERULAR HAEMODYNAMICS IN PATIENTS WITH HYPERTENSION: 3C.01
28. INVESTIGATING THE CRITICAL SITUATION IN HYPERTENSION MANAGEMENT: PHYSICIAN PERCEPTION AND USE OF THE ESH–ESC TREATMENT GUIDELINES (SHARE SURVEY): PP.20.306
29. CENTRALISED ECHOCARDIOGRAPHIC READING IN A CLINICAL TRIAL
30. URIC ACID LEVELS ARE ASSOCIATED WITH ENDOTHELIUM-DEPENDENT VASODILATATION
31. RAPID NONGENOMIC EFFECTS OF ALDOSTERONE IN ESSENTIAL HYPERTENSION
32. PLATELET P-SELECTIN AND PLASMA LEVELS OF CIRCULATING CYTOKINES IN YOUNG PATIENTS WITH MILD ESSENTIAL HYPERTENSION
33. THE P.I.C.χE.L. STUDY
34. CARDIAC STRUCTURAL ADAPTATION OF THE LEFT AND RIGHT VENTRICLE IN EARLY STAGES OF ESSENTIAL HYPERTENSION
35. INDAPAMIDE SR ANTIHYPERTENSIVE EFFICACY VS CANDESARTAN AND AMLODIPINE IN ISOLATED SYSTOLIC HYPERTENSIVE PATIENTS
36. A SINGLE NUCLEOTIDE POLYMORPHISM (SNP) IN THE HUMAN GLUTATHIONE S-TRANSFERASE MU TYPE 4 GENE (GSTM 4) IS ASSOCIATED WITH IMPAIRED ENDOTHELIAL FUNCTION AND ARTERIAL HYPERTENSION
37. APPLANATION TONOMETRY
38. IMPAIRED STIMULATED NO-ACTIVITY BY DARBEPOIETIN IN HYPERTENSIVE SUBJECTS
39. THE EFFECT OF VALSARTAN ON THE ENDOTHELIAL FUNCTION OF THE RETINAL CAPILLARY BED
40. DETERMINANTS OF THE NEW DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY ON TREATED HYPERTENSIVES
41. THE C242T P22PHOX GENOTYPE IS ASSOCIATED WITH INTIMA-MEDIA-THICKNESS
42. INCREASED EXPRESSION OF NITRIC OXIDE SYNTHASES IN HUMAN TYPE 2 DIABETIC NEPHROPATHY CORRELATES WITH CLINICAL RISK FACTORS OF DISEASE PROGRESSION
43. ANTIHYPERTENSIVE EFFICACY OF INDAPAMIDE SR VS CANDESARTAN AND AMLODIPINE IN HYPERTENSIVE PATIENTS
44. EFFECTS OF ULTRA HIGH DOSE CANDESARTAN (64MG) ON PROTEINURIA
45. Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate Hypercholesterolemia
46. Functional gene testing of the Glu298Asp polymorphism of the endothelial nitric oxide synthase
47. INCREASE IN CAROTID INTIMA MEDIA THICKNESS PARALLELS AN INCREASE IN LEFT VENTRICULAR MASS INDEX IN YOUNG NEVER TREATED HYPERTENSIVE MEN
48. POLYMORPHISMS OF THE ENDOTHELIAL NO-SYNTHASE (eNOS) DO NOT INFLUENCE ENDOTHELIAL FUNCTION IN HUMANS
49. Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension.
50. Reversal of Left Ventricular Hypertrophy in Essential Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.